Cutera Inc Stock Price, News & Analysis

Cutera, a leader in dermatology solutions, has announced the first patient treatment with AviClear, the sole FDA-cleared device for treating mild to severe acne. This follows its FDA 510k clearance on March 24, 2022. AviClear provides effective acne treatment with no need for pain therapy, using a unique handpiece that enhances patient comfort. The rollout of AviClear is set for 2022 across the United States, accompanied by the Avi360 partnership, which facilitates integration into dermatology practices.

AviClear has received FDA 510(k) clearance, becoming the first energy-based device approved for treating mild, moderate, and severe acne. This laser treatment is designed to provide a safe, prescription-free solution, targeting the source of acne by suppressing sebum production. Clinical trials demonstrate that AviClear not only reduces existing acne but also improves future breakout patterns, showing long-term efficacy without requiring pain mitigation. Cutera aims to introduce AviClear to physicians in the U.S. throughout 2022, revolutionizing acne treatment.

Cutera, Inc. (NASDAQ: CUTR), a leader in laser and energy-based aesthetic systems, announces CEO Dave Mowry's participation in the Aesthetic Device Industry Panel at the Maxim Virtual Growth Conference. The event is scheduled for 1:00 p.m. ET on March 28, 2022. Investors can register for the live event at m-vest.com. Established in 1998, Cutera specializes in developing innovative products that facilitate safe and effective aesthetic treatments for practitioners worldwide.

Cutera, Inc. (NASDAQ: CUTR) reported strong financial results for Q4 and full-year 2021. Q4 revenue reached $65.6 million, up 31% year-over-year, with Capital Equipment revenue at $43.6 million, a 44% increase. The full-year revenue was $231.3 million, a 57% rise. Despite a Q4 net loss of $3.9 million, the company showed improved gross margins of 58.2%. The outlook for 2022 projects revenue between $255 million to $260 million, excluding the Acne program, indicating ongoing growth potential.

Cutera, Inc. (CUTR) will announce its fourth quarter and full year 2021 financial results on February 22, 2022, after market close. The company provides laser and energy-based aesthetic systems globally. A conference call for discussing these results will take place at 1:30 p.m. PT the same day, with access numbers provided for both domestic and international participants. Additionally, the call will be webcasted for broader accessibility. Cutera, established in 1998, is dedicated to developing safe and effective aesthetic treatment solutions for practitioners.

Cutera (CUTR) announced the immediate addition of two new members, Janet Widmann and Juliane Park, to its Board of Directors. Widmann brings over 25 years of healthcare experience, while Park offers a unique blend of operational and strategic expertise in health and beauty sectors. The company believes that their extensive backgrounds will be instrumental in advancing its growth and market expansion strategies. This leadership change aims to enhance the company's strategic transformation and drive profitability.

Cutera, Inc. (Nasdaq: CUTR) has launched the next generation of its muscle sculpting technology, truSculpt flex+, which features a rapid treatment mode that reduces muscle sculpting sessions from 45 minutes to just 15. This innovation allows practitioners to treat eight areas simultaneously, addressing the growing demand for body sculpting treatments projected to increase in 2022. truSculpt flex+ is FDA-cleared for improving abdominal tone and strengthening buttocks and thighs, delivering muscle contractions equivalent to 54,000 crunches.

Cutera, Inc. (NASDAQ: CUTR), a provider of aesthetic laser systems, announced that CEO Dave Mowry will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference. The pre-recorded fireside chat will be accessible to registered attendees from 10:00 a.m. ET on November 22 until December 2, 2021, via the Piper Sandler conference site. It will also be available for replay on Cutera’s website. Cutera has been delivering innovative aesthetic solutions since 1998, enabling practitioners to provide safe and effective treatments.

Cutera, Inc. (NASDAQ: CUTR) announced that CEO Dave Mowry will participate in a virtual fireside chat at the Stifel Healthcare Conference on Tuesday, November 16, 2021, at 11:20 a.m. ET. The chat will provide insights into the company's innovative aesthetic systems and their impact on practitioners worldwide. Investors can access a live webcast through the company's website at www.cutera.com, with a replay available post-event. Cutera is known for its advanced laser and energy-based aesthetic treatments, enhancing safety and effectiveness for patients.